Table 2: Liver SOD, GSH, glycogen, total protein, and total lipid levels of control, TAA, TTA plus G. biloba leaves extract, and G. biloba leaves extract treated mice ( 𝑛 = 7). Percentage changes are included in parentheses.

ParametersTreatments
Control TAA TAA + leaves extract Leaves extract

SOD (U/mg tissue) 5 . 2 6 ± 0 . 6 7 3.47 ± 0.42ab4.23 ± 0.49ac5.34 ± 0.52
( 3 4 . 0 ) (−19.6)(+1.5)
GSH (μmol/g tissue) 8 . 6 9 ± 0 . 8 2 6.21 ± 0.55ab6.94 ± 0.62ac8.90 ± 0.68
(−28.5)(−20.1)(+2.4)
Glycogen (mg/g tissue) 9 . 3 4 ± 0 . 8 7 7.34 ± 1.19ab8.06 ± 0.81a9.03 ± 1.25
(−21.4)(−13.7)(−3.3)
Total protein (mg/g tissue) 2 4 7 . 4 3 ± 1 2 . 6 1 204.00 ± 8.43ab236.11 ± 17.58254.29 ± 18.63
( 1 7 . 6 % ) ( 4 . 6 % )(+2.8%)
Total lipid (mg/g tissue) 1 4 3 . 0 0 ± 8 . 7 6 195.43 ± 14.97ab177.14 ± 8.09ac140.29 ± 10.26
(+36.7)(+23.9) ( 1 . 9 )

aIndicates a significant difference between control and treated groups.
bIndicates a significant difference between the group treated with TAA and groups treated with TAA plus G. biloba leaves extract and G. biloba leaves extract.
cIndicates a significant difference between the group treated with TAA plus G. biloba leaves extract and group treated with G. biloba leaves extract.